HHS study shows Medicare pays 80 percent more than other countries for certain prescription drugs
FRIDAY, Oct. 26, 2018 (HealthDay News) — In an effort to cut high drug costs, the prices paid by Medicare for certain prescription drugs would be based on those in other advanced industrial nations, according to a proposal announced Oct. 25 by the Trump administration.
The move would cut costs for Medicare and save beneficiaries millions of dollars, according to an article in The New York Times.
Under a demonstration project in half the country, Medicare would create and use an “international pricing index” to decide how much to pay for drugs covered by Part B of Medicare.
A recently released study by the U.S. Department of Health and Human Services revealed that Medicare paid 80 percent more than other advanced industrial countries for some of the most expensive prescription medicines, The Times reported.
Reduction Seen in Services Following Launch of Prior Authorization Pilot Program 
Treatment Satisfaction Higher for Patients With RA Choosing Their Own Treatment .jpg)
Most Specialty Oral Anticancer Meds for Blood Cancers Are Initially Rejected by Insurers 
Drug Interactions Reducing Contraceptive Effectiveness Common in Epilepsy 
Characteristics of Individuals Diagnosed With Autism Have Changed Since 2010 
Holding DMARDs at Time of COVID-19 Vaccine Not Warranted in Those With Inflammatory Arthritis 
1 in 3 With Lupus Take Supplements, Medications With Potential for Interactions 
2013 to 2024 Saw Decrease in Benzodiazepine Prescribing .jpg)
